Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets
Provention Bio announced that it has entered into agreements with Janssen Pharmaceutica NV and Janssen Sciences Ireland UC to in-license two clinical-stage assets, PRV-6527…
Read More...
Read More...